Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
02 April, 2023 15:05 IST
Maintain Buy on GAIL; raises target price to Rs 155: IDBI Capital
Source: IRIS | 17 Feb, 2021, 05.39PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 GAIL (India) Q3FY21 EBITDA was largely in line while PAT was above our forecast led by higher than expected other income. Stellar performance by petrochemicals benefiting from highest-ever utilisation level at 114% was largely offset by third consecutive quarterly EBITDA loss at trading business. Gas transmission business volume remained flattish YoY (+4% QoQ) at 110.3 mmscmd while LHC business saw a marginal dip at its EBITDA level.

GAIL's management expect 5-7% rise in transmission volume in coming few years led by commissioning of new gas pipeline and demand from new fertiliser units in UP along with at least 110% utilisation level at its Petchem plant. Further, it expects stronger Q4FY21 owing to additional profit contribution from trading business which is likely to benefit from surge in spot LNG prices in Jan'21.

IDBI Capital
maintains 'Buy' rating on GAIL (India) with revised target price to Rs 155 from earlier Rs 109.

Commenting on the result review, the broking firm said, "We raise FY21/22/23 EBITDA by 5.7%/2.5%/3.1% in order to factor in stronger petchem business. Monetization of pipeline, higher volume and stronger LHC prices are few tailwinds for the company. We raise its TP to Rs 155 from earlier Rs 109. Maintain Buy."  

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer